Diffuse iris nevus.
Mahdavi Fard A, Pourafkari L, Nader ND.
QJM. 2016 Feb;109(2):137. doi: 10.1093/qjmed/hcv169. Epub 2015 Oct 1.
Iris pigmented lesions as a marker of cutaneous melanoma risk: an Australian case-control study.
Laino AM, Berry EG, Jagirdar K, Lee KJ, Duffy DL, Soyer HP, Sturm RA.
Br J Dermatol. 2018 May;178(5):1119-1127. doi: 10.1111/bjd.16323. Epub 2018 Apr 6.
Anterior Segment OCTA of Melanocytic Lesions of the Conjunctiva and Iris.
Brouwer NJ, Marinkovic M, Bleeker JC, Luyten GPM, Jager MJ.
Am J Ophthalmol. 2021 Feb;222:137-147. doi: 10.1016/j.ajo.2020.09.009. Epub 2020 Sep 12.
NEVUS OF OTA.
JUNCEDA J.
Am J Ophthalmol. 1965 May;59:923-5. doi: 10.1016/0002-9394(65)93030-8.
Balloon cell nevus of the iris.
Morcos MW, Odashiro A, Bazin R, Pereira PR, O'Meara A, Burnier MN Jr.
Pathol Res Pract. 2014 Dec;210(12):1160-3. doi: 10.1016/j.prp.2014.04.026. Epub 2014 May 16.
Iris nevus growth into melanoma: analysis of 1611 consecutive eyes: the ABCDEF guide.
Shields CL, Kaliki S, Hutchinson A, Nickerson S, Patel J, Kancherla S, Peshtani A, Nakhoda S, Kocher K, Kolbus E, Jacobs E, Garoon R, Walker B, Rogers B, Shields JA.
Ophthalmology. 2013 Apr;120(4):766-72. doi: 10.1016/j.ophtha.2012.09.042. Epub 2013 Jan 3.
Iris melanoma: Review of clinical features, risks, management, and outcomes.
Cherkas E, Kalafatis NE, Marous MR, Shields CL.
Clin Dermatol. 2024 Jan-Feb;42(1):62-70. doi: 10.1016/j.clindermatol.2023.10.009. Epub 2023 Oct 21.
Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
van Poppelen NM, Vaarwater J, Mudhar HS, Sisley K, Rennie IG, Rundle P, Brands T, van den Bosch QCC, Mensink HW, de Klein A, Kiliç E, Verdijk RM.
Ophthalmology. 2018 Jun;125(6):904-912. doi: 10.1016/j.ophtha.2017.12.022. Epub 2018 Jan 19.
Congenital uveal melanoma?
Singh AD, Schoenfield LA, Bastian BC, Aziz HA, Marino MJ, Biscotti CV.
Surv Ophthalmol. 2016 Jan-Feb;61(1):59-64. doi: 10.1016/j.survophthal.2015.07.005. Epub 2015 Aug 12.
Case Series: Different Presentations of Iris Melanoma-Potential Masquerade of Benign and Malignant.
Allen N, Misra SL, McGhee CNJ, Crawford AZ.
Optom Vis Sci. 2022 Mar 1;99(3):298-302. doi: 10.1097/OPX.0000000000001855.
